Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model
Open Access
- 3 June 2008
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (22) , 7863-7868
Abstract
Alzheimer's disease (AD) is associated with progressive memory decline. Hippocampal place cells are a well understood candidate for the neural basis of one type of memory in rodents; these cells identify the animal's location in an environment and are crucial for spatial memory and navigation. We have recorded place cells in the Tg2576 mouse model of AD, and we report that aged (16 mo) but not young (3 mo) transgenic mice show degraded neuronal representations of the environment. The level of place cell degradation correlates with the animals' (poorer) spatial memory as tested in a forced-choice spatial alternation T-maze task and with hippocampal, but not neocortical, amyloid plaque burden. Place cell recording provides a sensitive assay for measuring the amount and rate of functional deterioration in animal models of dementia as well as providing a quantifiable physiological indication of the beneficial effects of potential therapies.Keywords
This publication has 29 references indexed in Scilit:
- Experience-Dependent Increase in CA1 Place Cell Spatial Information, But Not Spatial Reproducibility, Is Dependent on the Autophosphorylation of the α-Isoform of the Calcium/Calmodulin-Dependent Protein Kinase IIJournal of Neuroscience, 2007
- Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 miceJournal of Comparative Neurology, 2006
- β-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or β-amyloid depositsProceedings of the National Academy of Sciences, 2006
- RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memoryNature, 2006
- Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2 S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7 S)-5-methyl-6-oxo-6,7-dihydro-5 H-dibenzo[b,d]azepin-7-yl]-l-alaninamide]The Journal of Pharmacology and Experimental Therapeutics, 2005
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Place navigation impaired in rats with hippocampal lesionsNature, 1982
- The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving ratBrain Research, 1971